Healthcare provider profile · identity verified

Catherine Marie Mitchell, DO

Family Practice · AURORA, MN · NPI 1043285455

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	403	117
Amlodipine Besylate	Amlodipine Besylate	260	86
Levothyroxine Sodium	Levothyroxine Sodium	248	71
Lisinopril	Lisinopril	223	69
Losartan Potassium	Losartan Potassium	191	58
Omeprazole	Omeprazole	184	54
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	172	23
Metoprolol Succinate	Metoprolol Succinate	162	47
Albuterol Sulfate Hfa	Albuterol Sulfate	142	32
Metoprolol Tartrate	Metoprolol Tartrate	142	40
Metformin Hcl	Metformin Hcl	136	39
Furosemide	Furosemide	130	35
Gabapentin	Gabapentin	119	41
Rosuvastatin Calcium	Rosuvastatin Calcium	115	36
Prednisone	Prednisone	105	68
Hydrochlorothiazide	Hydrochlorothiazide	103	30
Simvastatin	Simvastatin	103	25
Sertraline Hcl	Sertraline Hcl	98	28
Metformin Hcl Er	Metformin Hcl	80	24
Tamsulosin Hcl	Tamsulosin Hcl	72	23
Warfarin Sodium	Warfarin Sodium	70	15
Dulera	Mometasone/Formoterol	64	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	61	20
Xarelto	Rivaroxaban	61	suppressed
Fluticasone Propionate	Fluticasone Propionate	60	24
Ibuprofen	Ibuprofen	53	suppressed
Potassium Chloride	Potassium Chloride	53	19
Quetiapine Fumarate	Quetiapine Fumarate	53	suppressed
Valsartan	Valsartan	53	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	52	suppressed
Ozempic	Semaglutide	52	11
Ventolin Hfa	Albuterol Sulfate	50	14
Famotidine	Famotidine	47	18
Jardiance	Empagliflozin	47	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	17
Clonazepam	Clonazepam	43	11
Eliquis	Apixaban	43	12
Fluoxetine Hcl	Fluoxetine Hcl	42	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	42	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	41	suppressed
Atenolol	Atenolol	40	12
Trazodone Hcl	Trazodone Hcl	40	12
Alprazolam	Alprazolam	39	suppressed
Tramadol Hcl	Tramadol Hcl	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	11
Clopidogrel	Clopidogrel Bisulfate	36	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	13
Triamcinolone Acetonide	Triamcinolone Acetonide	35	26
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Cefdinir	Cefdinir	34	25
Bupropion Xl	Bupropion Hcl	33	suppressed
Carvedilol	Carvedilol	33	11
Jantoven	Warfarin Sodium	32	suppressed
Allopurinol	Allopurinol	31	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	18
Lorazepam	Lorazepam	31	suppressed
Montelukast Sodium	Montelukast Sodium	31	11
Celecoxib	Celecoxib	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	12
Glipizide	Glipizide	28	suppressed
Breyna	Budesonide/Formoterol Fumarate	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	12
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Amoxicillin	Amoxicillin	23	21
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	13
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Baclofen	Baclofen	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Divalproex Sodium	Divalproex Sodium	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Azithromycin	Azithromycin	19	18
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Cephalexin	Cephalexin	18	15
Meloxicam	Meloxicam	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	11
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Minocycline Hcl	Minocycline Hcl	14	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Fluconazole	Fluconazole	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Indapamide	Indapamide	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Estradiol	Estradiol	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error